I am a breastfeeding mother and i want to know if it is safe to use Omnipaque 210? Is Omnipaque 210 safe for nursing mother and child? Does Omnipaque 210 extracts into breast milk? Does Omnipaque 210 has any long term or short term side effects on infants? Can Omnipaque 210 influence milk supply or can Omnipaque 210 decrease milk supply in lactating mothers?
- DrLact safety Score for Omnipaque 210 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of Omnipaque 210 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that Omnipaque 210 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of Omnipaque 210 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
X-ray contrast medium that contains 46% of Iodine. Omnipaque 210 is excreted into breast milk in clinically non-significant amount (Nielsen, 1987).It has been used in neonates and young infants. The various iodinated contrast media for imaging examinations (X-rays, CT scans) are considered compatible with breastfeeding since they are rapidly eliminated with little or no release of iodine, not metabolized and virtually not absorbed when taken by mouth. They are structurally very similar to each other and one of them is their data no or minimal excretion in milk. Given the low lipid solubility of the iodinated contrast, less than 1% of the dose administered to the mother just passing milk.Due to their low oral bioavailability, intestinal absorption is less than 1% of the dose that he may take the infant.The maximum dose just getting the baby is less than 0.01% of the maternal dose, which represents less than 1% of the dose administered to a nursing practice that is a radiological contrast examination. Most radiology scientific societies agree that after a radiological iodinated contrast examination is not necessary to wait any time to resume nursing.
Limited information indicates that maternal doses of Omnipaque 210 up to 45.3 grams (containing 21 grams of iodine) produce low levels in milk. In addition, because Omnipaque 210 is poorly absorbed orally, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. The manufacturer states that withholding breastfeeding for 10 hours after administration to minimize the exposure of the infant; however, guidelines developed by several professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a iodine-containing contrast medium.[1][2][3][4]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.